timolol has been researched along with Epidermolysis Bullosa Junctionalis, Disentis Type in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiaverini, C; Lacour, JP; Passeron, T | 1 |
1 other study(ies) available for timolol and Epidermolysis Bullosa Junctionalis, Disentis Type
| Article | Year |
|---|---|
Topical timolol for chronic wounds in patients with junctional epidermolysis bullosa.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Chronic Disease; Epidermolysis Bullosa, Junctional; Humans; Infant; Timolol; Wound Healing | 2016 |